Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ)
CNY 32.71
(-0.58%)
CNY 32.71
(-0.58%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 869.79 Million | 970.8 Million | 1.18 Billion | 1.37 Billion | 1.5 Billion | 1.34 Billion |
| Net Income | 580.06 Million | 634.21 Million | 528.32 Million | 50.13 Million | 681.84 Million | 1.45 Billion |
| Depreciation & Amortization | 375.43 Million | 320.15 Million | 304.26 Million | 246.02 Million | 229.36 Million | 167.36 Million |
| Deferred income taxes | -13.12 Million | 20.92 Million | -3.57 Million | -37.13 Million | -7.76 Million | -1.12 Million |
| Stock-based compensation | 25.91 Million | - | - | - | - | - |
| Change in working capital | -163.98 Million | -140.91 Million | 297.41 Million | 740.02 Million | 367.61 Million | -272.87 Million |
| Other non-cash items | 1 Billion | 135.68 Million | 54.97 Million | 338.14 Million | 227.82 Million | -8.39 Million |
| Investing Cash Flow | -1.4 Billion | -1.27 Billion | -369.64 Million | -849.43 Million | -212.3 Million | -933.02 Million |
| Investments in PPE | -670.99 Million | -598.96 Million | -482.5 Million | -642.46 Million | -457.18 Million | -332.86 Million |
| Acquisitions | 614.99 Thousand | -82.84 Million | 1.59 Million | 643.35 Million | 457.33 Million | -213.89 Million |
| Investment purchases | -2.14 Billion | -1.37 Billion | -498.07 Million | -858.29 Million | -2.38 Billion | -2.79 Billion |
| Sales/Maturities of investments | 1.41 Billion | 696.15 Million | 609.33 Million | 650.42 Million | 2.63 Billion | 2.4 Billion |
| Other Investing Activities | 1.00 | 83.42 Million | 0.79 | -642.46 Million | -457.18 Million | 729.86 Thousand |
| Financing Cash Flow | -705.53 Million | -401.5 Million | 1.54 Billion | -766.85 Million | -829.59 Million | -597.23 Million |
| Debt repayment | -134.89 Million | -183.6 Million | -639.51 Million | -277.71 Million | -37.7 Million | -74.5 Million |
| Dividends payments | -545.67 Million | -437.56 Million | -1.6 Million | -515.92 Million | -836.81 Million | -843.45 Million |
| Common Stock Repurchased | - | -274.3 Million | -327.85 Million | -284.94 Million | -63.13 Million | - |
| Common Stock Issuance | - | 300.5 Million | 392.35 Million | 284.94 Million | 63.13 Million | - |
| Other Financing Activities | -24.96 Million | 197.1 Million | 2.13 Billion | 45.67 Million | 60.86 Million | 320.72 Million |
| Accounts receivables | 3.96 Million | -89.41 Million | 69.97 Million | 613.44 Million | 356.35 Million | -61.1 Million |
| Accounts payables | -219.18 Million | 41.69 Million | 277.53 Million | 52.28 Million | -48.51 Million | -123.72 Million |
| Inventory | 51.23 Million | -114.11 Million | -46.53 Million | 111.42 Million | 67.54 Million | -86.93 Million |
| Other working capital | 1.00 | 20.92 Million | -3.57 Million | -37.13 Million | -7.76 Million | -185.94 Million |
| Cash at beginning of period | 2.67 Billion | 3.22 Billion | 865.13 Million | 1.11 Billion | 645.11 Million | 828.92 Million |
| Cash at end of period | 1.32 Billion | 2.55 Billion | 3.22 Billion | 865.13 Million | 1.11 Billion | 645.11 Million |
| Capital Expenditure | -670.99 Million | -598.96 Million | -482.5 Million | -642.46 Million | -457.18 Million | -332.86 Million |
| Effect of forex changes on cash | 4.06 Million | 32.96 Million | -6.77 Million | -4.83 Million | 2.08 Million | 5.78 Million |
| Net cash flow / Change in cash | -1.34 Billion | -671.04 Million | 2.35 Billion | -246.8 Million | 466.83 Million | -183.81 Million |
| Free Cash Flow | 198.79 Million | 371.84 Million | 702.47 Million | 731.86 Million | 1.04 Billion | 1 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 165.62 Million | 143.82 Million | 200.26 Million | 580.06 Million | 100.89 Million | 141.55 Million |
| Depreciation & Amortization | - | 99.33 Million | 99.33 Million | 375.43 Million | 101.19 Million | -157.06 Million |
| Deferred income taxes | - | - | - | -13.12 Million | -81.1 Million | 52.36 Million |
| Stock-based compensation | - | 14.05 Million | - | 25.91 Million | 25.91 Million | -12.42 Million |
| Change in working capital | - | -62.11 Million | - | -163.98 Million | 55.19 Million | 114.28 Million |
| Other non-cash items | 157.57 Million | 276.93 Million | 32.65 Million | 1 Billion | 124.52 Million | 42.76 Million |
| Investing Cash Flow | -533.9 Million | -586.29 Million | -106.55 Million | -1.4 Billion | -602.39 Million | -392.5 Million |
| Investments in PPE | -173.35 Million | -156.68 Million | -114.36 Million | -670.99 Million | -152.77 Million | -305.73 Million |
| Acquisitions | 284.71 Thousand | 153.09 Thousand | 11.94 Thousand | 614.99 Thousand | 278.74 Thousand | 110 Thousand |
| Investment purchases | -795.91 Million | -1.01 Billion | -150 Million | -2.14 Billion | -1.11 Billion | -225.02 Million |
| Sales/Maturities of investments | 435.23 Million | 581.58 Million | 157.79 Million | 1.41 Billion | 665.1 Million | 138.15 Million |
| Other Investing Activities | 136.57 Thousand | -411.11 Million | 7.8 Million | 1.00 | 1.00 | -11.47 Thousand |
| Financing Cash Flow | 308.4 Million | -209.32 Million | -33.82 Million | -705.53 Million | -158.12 Million | 89.15 Million |
| Debt repayment | -49.65 Million | - | -29.83 Million | -134.89 Million | -148.09 Million | -35.8 Million |
| Dividends payments | -317.72 Million | -228.12 Million | -92.26 Thousand | -545.67 Million | -545.67 Million | -588.82 Thousand |
| Common Stock Repurchased | 7.25 Million | -7.25 Million | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 576.47 Million | -202.07 Million | -3.89 Million | -24.96 Million | 535.65 Million | 125.54 Million |
| Accounts receivables | - | -82.27 Million | - | 3.96 Million | 3.96 Million | 172.23 Million |
| Accounts payables | - | - | - | -219.18 Million | - | - |
| Inventory | - | 20.16 Million | - | 51.23 Million | 51.23 Million | -57.94 Million |
| Other working capital | - | - | - | 1.00 | - | - |
| Cash at beginning of period | 936.1 Million | 1.41 Billion | 1.31 Billion | 2.67 Billion | 1.78 Billion | 1.88 Billion |
| Cash at end of period | 1.02 Billion | 936.21 Million | 1.4 Billion | 1.32 Billion | 1.32 Billion | 1.75 Billion |
| Capital Expenditure | -173.35 Million | -156.68 Million | -114.36 Million | -670.99 Million | -152.77 Million | -305.73 Million |
| Effect of forex changes on cash | -7.16 Million | 1.77 Million | 617.81 Thousand | 4.06 Million | -5.6 Million | -2.72 Million |
| Net cash flow / Change in cash | 88.18 Million | -477.47 Million | 90.36 Million | -1.34 Billion | -459.18 Million | -124.58 Million |
| Free Cash Flow | 149.83 Million | 164.74 Million | 118.56 Million | 198.79 Million | 173.83 Million | -124.24 Million |
JWTXF
MGLU3
ICN
5704
DVAX
NTC